
How GLP-1 drugs are supercharging the age of precision nutrition
Could the era of precision nutrition turn the pharma-driven metabolism revolution into a food-based one?
All stories

Could the era of precision nutrition turn the pharma-driven metabolism revolution into a food-based one?

As GLP-1 drugs disrupt the weight loss market, food and beverage players are racing to unlock the appetite-regulating power of functional ingredients

As usage of weight loss medications surges and new therapies emerge, food businesses face a once-in-a-generation opportunity – or risk being left behind

AI can speed up your pipeline – but it won’t tell you why everyone still picks chocolate. Here’s how to innovate without losing your edge

With an ambitious growth target for the next five years, vice president of new innovation territories at Mars, Greg Hocking, explains how it’ll achieve it through fun formats, functionality and fostering sustainable start-ups

Our site has moved to a new platform to improve your reading experience. Here’s what to look out for